NCT06397963View on ClinicalTrials.gov

Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients with Solid Tumours

NARecruitingINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

April 18, 2024

Primary Completion Date

April 18, 2027

Study Completion Date

April 18, 2027

Conditions

Solid Tumor, Adult

Interventions

BIOLOGICAL

GT307 injection

GT307 injection to treat solid tumours

Trial Locations (2)

221000

RECRUITING

The Affiliated Hospital Of Xuzhou Medical University, Xuzhou

Unknown

RECRUITING

Beijing Gobroad hospital, Beijing

Sponsors

Lead Sponsor

Grit Biotechnology

All Listed Sponsors

lead

Grit Biotechnology

INDUSTRY